Montelukast added to fluticasone propionate does not alter inflammation or outcomes
Background Airway inflammation is a key pathological feature of asthma which underlies its clinical presentation. Objectives To examine whether adding a leukotriene modifier to an inhaled corticosteroid produces further clinical and/or anti-inflammatory benefits in patients symptomatic on short-a...
Main Authors: | Djukanović, Ratko (Author), Wilson, Susan J. (Author), Moore, Wendy C. (Author), Koenig, Steven M. (Author), Laviolette, Michel (Author), Bleecker, Eugene (Author), Davis, W. Bruce (Author), Doherty, Dennis E. (Author), Olivenstein, Ronald (Author), Israel, Elliot (Author), Kavuru, Mani (Author), Kleerup, Eric (Author), Reilly, Donna S. (Author), Yancey, Steven (Author), Edwards, Lisa D. (Author), Stauffer, John L. (Author), Dorinsky, Paul M. (Author), Jarjour, Nizar N. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2010-10.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
by: Woodcock Ashley, et al.
Published: (2007-09-01) -
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
by: Stanford RH, et al.
Published: (2012-12-01) -
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma
by: Yoxall Sally, et al.
Published: (2007-07-01) -
Fluticasone Propionate in Inflammatory Bowel Disease
by: Marta Carpani de Kaski, et al.
Published: (1990-01-01) -
Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
by: Harsha H Kariyawasam, et al.
Published: (2010-06-01)